These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1199 related items for PubMed ID: 23212935

  • 1. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of linezolid, daptomycin, and vancomycin in methicillin-resistant Staphylococcus aureus: complicated skin and skin structure infection using Bayesian methods for evidence synthesis.
    Bounthavong M, Zargarzadeh A, Hsu DI, Vanness DJ.
    Value Health; 2011 Dec; 14(5):631-9. PubMed ID: 21839399
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Usery JB, Vo NH, Finch CK, Cleveland KO, Gelfand MS, Self TH.
    Am J Med Sci; 2015 Jan; 349(1):36-41. PubMed ID: 25233042
    [Abstract] [Full Text] [Related]

  • 4. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
    Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.
    Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947
    [Abstract] [Full Text] [Related]

  • 5. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    McKinnon PS, Sorensen SV, Liu LZ, Itani KM.
    Ann Pharmacother; 2006 Jun 01; 40(6):1017-23. PubMed ID: 16720705
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of linezolid, tigecycline, and daptomycin on methicillin-resistant Staphylococcus aureus blood isolates from adult patients, 2006-2008: stratified analysis by vancomycin MIC.
    Kao TM, Wang JT, Weng CM, Chen YC, Chang SC.
    J Microbiol Immunol Infect; 2011 Oct 01; 44(5):346-51. PubMed ID: 21524980
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.
    Murray KP, Zhao JJ, Davis SL, Kullar R, Kaye KS, Lephart P, Rybak MJ.
    Clin Infect Dis; 2013 Jun 01; 56(11):1562-9. PubMed ID: 23449272
    [Abstract] [Full Text] [Related]

  • 10. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis.
    Sipahi OR, Bardak-Ozcem S, Turhan T, Arda B, Ruksen M, Pullukcu H, Aydemir S, Dalbasti T, Yurtseven T, Sipahi H, Zileli M, Ulusoy S.
    Surg Infect (Larchmt); 2013 Aug 01; 14(4):357-62. PubMed ID: 23672240
    [Abstract] [Full Text] [Related]

  • 11. Pharmacotherapy for methicillin-resistant Staphylococcus aureus nosocomial pneumonia.
    Segarra-Newnham M, Church TJ.
    Ann Pharmacother; 2012 Dec 01; 46(12):1678-87. PubMed ID: 23232021
    [Abstract] [Full Text] [Related]

  • 12. [Lipopeptides and oxazolidinones--novel antibiotics in MRSA infection treatment].
    Pangercić A, Bukovski-Simonoski S, Barsić B.
    Lijec Vjesn; 2010 Dec 01; 132 Suppl 1():11-3. PubMed ID: 20715711
    [Abstract] [Full Text] [Related]

  • 13. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
    Rio-Marques L, Hartke A, Bizzini A.
    Microb Drug Resist; 2014 Dec 01; 20(6):539-43. PubMed ID: 25010140
    [Abstract] [Full Text] [Related]

  • 14. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM, Prakhya A, Hammel JP, Ambrose PG.
    Clin Infect Dis; 2009 Sep 01; 49(5):691-8. PubMed ID: 19635023
    [Abstract] [Full Text] [Related]

  • 15. Randomized non-inferiority trial to compare trimethoprim/sulfamethoxazole plus rifampicin versus linezolid for the treatment of MRSA infection.
    Harbarth S, von Dach E, Pagani L, Macedo-Vinas M, Huttner B, Olearo F, Emonet S, Uçkay I.
    J Antimicrob Chemother; 2015 Jan 01; 70(1):264-72. PubMed ID: 25209610
    [Abstract] [Full Text] [Related]

  • 16. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Kullar R, Davis SL, Kaye KS, Levine DP, Pogue JM, Rybak MJ.
    Pharmacotherapy; 2013 Jan 01; 33(1):3-10. PubMed ID: 23307539
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Daptomycin plus trimethoprim/sulfamethoxazole combination therapy in post-neurosurgical meningitis caused by linezolid-resistant Staphylococcus epidermidis.
    Vena A, Falcone M, Comandini E, Meledandri M, Novelli A, Campanile F, Stefani S, Venditti M.
    Diagn Microbiol Infect Dis; 2013 May 01; 76(1):99-102. PubMed ID: 23453066
    [Abstract] [Full Text] [Related]

  • 19. Outcomes and costs associated with a history of vancomycin exposure in patients with MRSA-related complicated bacteremia and infective endocarditis.
    Brown J, Brown KA, Forrest A.
    Clin Ther; 2011 Oct 01; 33(10):1475-82. PubMed ID: 21925733
    [Abstract] [Full Text] [Related]

  • 20. Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.
    Adra M, Lawrence KR.
    Ann Pharmacother; 2004 Feb 01; 38(2):338-41. PubMed ID: 14742775
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 60.